References
- 1. Barth H, Liang TJ, Baumert TF. Hepatitis C virus entry: molecular biology and clinical implications. Hepatology. 2006; 44:527-35.10.1002/hep.21321
- 2. UNAIDS. Annual Report 2008. [cited 2011 May 1].
- Available from: <http://www.unaids.org/en>.
- 3. National AIDS Control Programme (NACP); 2008. [cited 2011 May 1]. Available from <http://www.nacp.gov.pk>.
- 4. Daneel S, Schüpbach J, Gebhardt M, Werner M, Staub R, Vernazza P. A prospective evaluation of the feasibility and utility of additional tools to obtain information from recently diagnosed HIV infected patients. Swiss Med Wkly. 2008; 138:453-8.
- 5. Ahmed MA, Zafar T, Brahmbhatt H, Imam G, Ul Hassan S, Bareta JC, Strathdee SA. HIV/AIDS Risk Behaviors and Correlates of Injection Drug Use among Drug Users in Pakistan. J Urban Health. 2003; 80: 321-9.10.1093/jurban/jtg034
- 6. Safi SZ, Badshah Y, Waheed Y, Fatima K, Tahir S, Shinwari A, Qadri I. Distribution of hepatitis C virus genotypes, hepatic steatosis and their correlation with clinical and virological factors in Pakistan. Asian Biomed. 2010; 2:253-62.
- 7. Waheed Y, Shafi T, Safi SZ, Qadri I. Hepatitis C virus in Pakistan: a systematic review of prevalence, genotypes and risk factors. World J Gastroenterol. 2009; 15:5647-53.10.3748/wjg.15.5647
- 8. Waheed Y, Saeed U, Safi SZ, Chaudhry WN, Qadri I. Awareness and risk factors associated with barbers in transmission of hepatitis B and C from Pakistani population: barber’s role in viral transmission. Asian Biomed. 2010; 4:435-42.
- 9. Shah SMA, Khan MT, Zahour Ullah, Ashfaq NY. Prevalence of Hepatitis B, Hepatitis C virus infection in multi-transfused thalassaemia major patients in North West Frontier Province. Pak Med J Sci. 2005; 21: 281-4.
- 10. Mujeeb SA, Pearce MS. Seroprevalence and determinants of risk of hepatitis B and C viral infections in blood donors: a cross sectional analytical study. J Infect Developing Countries. 2007; 1:17-24.
- 11. Fayyaz M, Qazi MA, Ahmed G, Khan MA, Chaudhary GMD. Hepatitis B, C & HIV; Seroprevalence of infection in Blood Donors. Professional Med J 2006; 13:632-6.
- 12. Sirhindi GA, Khan AA, Alam SS, Ghori MA, Rehman R, Soomro NA, Ahmed Z, Naeem MS, Shah WH, Hussain A, Chohan RA. Frequency of Hepatitis B, C and Human Immunodeficiency virus in blood donors at Shaikh Zayed Hospital, Lahore. Proceeding Shaikh Zayed Postgrad Med Inst. 2005; 19:33-6.
- 13. Asif N, Khokhar N, Ilahi F. Seroprevalence of HBV, HCV and HIV infection among voluntary non remunerated and replacement donors in northern Pakistan. Pak J Med Sci. 2004; 20:24-8.
- 14. Mumtaz S, Rehman MU, Muzaffar M, Hassan M, Iqbal W. Frequency of seropositive blood donors for hepatitis B, C and HIV viruses in railway hospital Rawalpindi. Pak. J. Med. Research. 2002; 41:51-3.
- 15. Patterson TL, Semple SJ. Sexual Risk Reduction among HIV-Positive Drug-Using Men Who Have Sex with Men. J Urban Health. 2003; 80:iii77-87.10.1093/jurban/jtg085
- 16. Deshpande A, Kumar A, Khodaiji S, Gupta AD. Prevalence of hepatitis C virus antibody in healthy blood donors. Indian J Hemat Blood Transf. 1998; 16:71-2.
- 17. Yanase Y, Ohida T, Kaneita Y, Agdamag DM, Leano PS, Gill CJ. The prevalence of HIV, HBV and HCV among Filipino blood donors and overseas work visa applicants. Bull World Health Organ. 2007; 85:131-7.10.2471/BLT.06.033365
- 18. Akhtar S, Younus M, Adil S, Jafri SH, Hassan F. Hepatitis C virus infection in asymptomatic male volunteer blood donors in Karachi, Pakistan. J Viral Hepat. 2004; 11:527-35.
- 19. Luby S, Khanani R, Zia M, Vellani Z, Ali M, Qureshi AH, Khan AJ, Mujeeb SA, Shah SA, Fisher-Hoch S. Evaluation of blood bank practices in Karachi, Pakistan, and the government response. Health Policy Plan 2000; 15:217-22.